Literature DB >> 7620092

Hospitalization among United States dialysis patients: hemodialysis versus peritoneal dialysis.

G Habach1, W E Bloembergen, E A Mauger, R A Wolfe, F K Port.   

Abstract

Measurements of hospitalization in the dialysis population are important because they provide insight into the morbidity and the cost of treatment among dialysis patients. Prior comparisons of hospitalization for different dialysis modalities have had conflicting results. This study was designed to compare hospitalization for patients treated with peritoneal dialysis (PD) versus hemodialysis (HD) using the data from the U.S. Renal Data System 1993 Annual Data Report. The study population included all Medicare dialysis patients prevalent on January 1, 1988 through 1990. Patients were monitored to transplantation, death, or end of the calendar year for a total of 189,654 patient years. Hospital admission rates were computed from the total number of hospital admissions during the year divided by the total number of patient years at risk. Patients were classified by treatment modality (PD, HD), cause of ESRD (diabetes as a cause of ESRD versus all other causes), age (0 to 19, 20 to 44, 45 to 65, +65), and race (black, white). Rate ratios (RR:PD/HD) for hospital admissions per year at risk were estimated, while adjusting for the other factors with Poison regression. On average, hospital admission rates per patient year at risk for dialysis patients treated with PD were 14% higher than for those treated with HD (RR = 1.14; 95% confidence interval (Cl), 1.13 to 1.15) when adjusting for race, age, gender, and cause of ESRD. The excess in the overall adjusted admission rates in PD patients compared with HD patients was higher for black than for white patients (RR:PD/HD = 1.22 versus RR = 1.11; 95% Cl, 1.10 to 1.13).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7620092     DOI: 10.1681/ASN.V5111940

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  6 in total

Review 1.  Statistical Methods for Recurrent Event Analysis in Cohort Studies of CKD.

Authors:  Wei Yang; Christopher Jepson; Dawei Xie; Jason A Roy; Haochang Shou; Jesse Yenchih Hsu; Amanda Hyre Anderson; J Richard Landis; Jiang He; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-17       Impact factor: 8.237

2.  Hospital admissions in elderly patients on chronic hemodialysis.

Authors:  Yijuan Sun; Hussein Kassam; Muniru Adeniyi; Milagros Martinez; Emmanuel I Agaba; Aideloje Onime; Karen S Servilla; Dominic S C Raj; Glen H Murata; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2011-03-02       Impact factor: 2.370

3.  Effect of Combining Conventional and Telehealth Methods on Managing Peritoneal Dialysis Patients: A Retrospective Single-Center Study.

Authors:  Zhi Wang; Wenjing Yan; Ying Lu; Kai Song; Huaying Shen; Yun Wang; Sheng Feng
Journal:  Int J Clin Pract       Date:  2022-03-03       Impact factor: 3.149

4.  Impact of modality choice on rates of hospitalization in patients eligible for both peritoneal dialysis and hemodialysis.

Authors:  Robert R Quinn; Pietro Ravani; Xin Zhang; Amit X Garg; Peter G Blake; Peter C Austin; James M Zacharias; John F Johnson; Sanjay Pandeya; Mauro Verrelli; Matthew J Oliver
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

5.  Trimethylamine-N-oxide is an independent risk factor for hospitalization events in patients receiving maintenance hemodialysis.

Authors:  Yin Zheng; Zihui Tang; Li You; Yuanhao Wu; Junfeng Liu; Jun Xue
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

6.  Hospitalization for Patients on Combination Therapy With Peritoneal Dialysis and Hemodialysis Compared With Hemodialysis.

Authors:  Mototsugu Tanaka; Yoshitaka Ishibashi; Yoshifumi Hamasaki; Yuka Kamijo; Mayumi Idei; Takuya Kawahara; Takahiro Nishi; Michio Takeda; Hiroshi Nonaka; Masaomi Nangaku; Naobumi Mise
Journal:  Kidney Int Rep       Date:  2020-01-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.